文献速递妇科

大麻素受体CB1在小鼠子宫内膜异位症模型中促进异位病灶发展

The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis.
PubMed 文献 · Hum Reprod · 2016-11-07

本研究在小鼠子宫内膜异位症模型中进行随机实验,发现CB1受体激动剂methanandamide(MET,5 mg/kg)处理组病灶总体积显著高于载体对照组(P < 0.05),而CB1-/-小鼠及接受CB1-/-供体组织的野生型受体小鼠病灶体积显著减小,提示CB1信号参与异位病灶发展。

要点

  • MET处理组病灶总体积显著高于载体组(P < 0.05)。
  • CB1-/-受体接受CB1-/-或WT供体组织、WT受体接受CB1-/-供体组织,病灶体积均较WT-WT组显著减小(P < 0.05)。
  • 作者认为CB1信号通路在小鼠子宫内膜异位症病灶发展中起作用,但在人类中的意义需进一步研究。

核心结论

  • CB1受体激动剂处理的小鼠异位病灶更大,而CB1功能缺失时病灶较轻,提示内源性大麻素系统通过CB1受体参与小鼠子宫内膜异位症病灶发展。
  • 作者指出该研究在小鼠模型中进行,其发现在人类系统中的意义需要进一步研究。

研究设计与样本

  • 随机研究,使用Balb/c和C57/Bl6小鼠子宫内膜异位症模型。
  • 第一组实验:MET(5 mg/kg)在第1-5天和第8-12天给药,n = 20。
  • 第二组实验:评估CB1-/-小鼠及其野生型(WT)同窝仔的子宫内膜异位症发展。
  • 疾病诱导两周后计数和测量病灶,部分用于免疫组化,部分冻存用于半定量实时PCR基因表达分析。

主要发现

  • MET处理组病灶总体积显著高于载体对照组(P < 0.05)。
  • MET处理组异位内膜中survivin、N-cadherin、整合素β1和白细胞介素-6的mRNA表达水平较载体组升高(P < 0.05)。
  • CB1-/-受体接受CB1-/-供体组织、WT受体接受CB1-/-供体组织、CB1-/-受体接受WT供体组织,其病灶总体积及survivin和N-cadherin表达均较WT受体接受WT供体组织者显著降低(P < 0.05)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • CB1介导的信号通路在炎症细胞、子宫细胞和腹膜细胞中的相对贡献尚待确定。
  • 研究在小鼠模型中进行,其发现在人类系统中的意义需要进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does signaling via the cannabinoid (CB1) receptor play a role in the pathogenesis of endometriosis in a mouse model? SUMMARY ANSWER: Mice treated with a CB1 agonist developed larger ectopic lesions, while less severe lesions developed in the absence of functional CB1 expression. WHAT IS KNOWN ALREADY: The expression of components of the endocannabinoid system has been demonstrated in both mouse and human uteri. CB1 receptors are expressed in human epithelial and stromal cell lines derived from eutopic endometrium and deep infiltrating endometriosis nodules. STUDY DESIGN, SIZE, DURATION: This was a randomized study in a mouse model of endometriosis. In a first set of experiments, mice with endometriosis were treated with the CB1 receptor agonist methanandamide (MET) (5 mg/kg, n = 20) on Days 1-5 and 8-12. In a second set of experiments, endometriosis development was evaluated in CB1-/- mice and in their wild-type (WT) littermates. PARTICIPANTS/MATERIALS, SETTING, METHODS: Endometriosis-like lesions were induced in Balb/c and C57/Bl6 mice. Two weeks after disease induction, the lesions were counted, measured and either included for immunohistochemistry analysis or frozen for gene expression profiling by semi-quantitative real-time PCR. To limit the role of chance, the experiments were conducted under standardized laboratory conditions with appropriate controls. MAIN RESULTS AND THE ROLE OF CHANCE: The lesion total volume was significantly higher in MET-treated compared with vehicle-treated mice (P < 0.05). Expression levels of mRNA for survivin, N-cadherin, integrin β1 and interleukin-6 were increased in the ectopic endometrium of MET-treated versus vehicle-treated mice (P < 0.05). CB1-/- recipients that received endometrial tissue fragments from CB1-/- donors, WT recipients that received endometrial tissue fragments from CB1-/- donors and CB1-/- recipients that received endometrial tissue fragments from WT donors all showed a significant reduction in total lesion volume and lower expression of survivin and N-cadherin compared with WT recipients receiving uterine fragments from WT donors (P < 0.05). LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: We provide evidence that endocannabinoid signaling via CB1 receptor plays a role in the development of endometriosis in a mouse model. However, the relative contribution of the CB1-mediated signaling pathways active in inflammatory, uterine and peritoneal cells remains to be ascertained. Since the study was performed in a mouse model, the significance of the findings in the human system warrants further investigation. WIDER IMPLICATIONS OF THE FINDINGS: Clarifying the function and regulation of CB1 and its molecular interactions with endogenous ligands, and how endocannabinoids levels are regulated in women with endometriosis, represent critical areas of research for the potential development of a novel medical treatment of the disease. STUDY FUNDING/COMPETING INTERESTS: A.M.S. was supported by a fellowship from Fondazione Giorgio Pardi. The authors have no conflicts of interest to declare.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Sanchez AM, Quattrone F, Pannese M, et al. The cannabinoid receptor CB1 contributes to the development of ectopic lesions in a mouse model of endometriosis. Hum Reprod. 2016. PMID: 27821707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。